Want to see MDLN full AI Analyst Report?
Medline (MDLN) Stock Statistics & Valuation Metrics
Total Valuation
Medline has a market cap or net worth of $44.82B. The enterprise value is $50.93B.
- Market Cap
- $44.82B
- Enterprise Value
- $50.93B
Share Statistics
Medline has 877,351,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 877,351,200
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Medline’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 5.69%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 5.69%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 631.82K
- Profits Per Employee
- 25.76K
- Employee Count
- 45,000
- Asset Turnover
- 0.74
- Inventory Turnover
- 4.39
Valuation Ratios
The current PE Ratio of Medline is 59.34. Medline’s PEG ratio is -1.33.
- PE Ratio
- 59.34
- PS Ratio
- 1.15
- PB Ratio
- 4.50
- Price to FCF
- 14.91
- Price to Operating Cash Flow
- 22.31
- PEG Ratio
- -1.33
Income Statement
In the last 12 months, Medline had revenue of 28.43B and earned 1.16B in profits. Earnings per share was 1.43.
- Revenue
- 28.43B
- Gross Profit
- 7.52B
- Operating Income
- 2.21B
- Pretax Income
- 1.25B
- Net Income
- 1.16B
- EBITDA
- 2.26B
- Earnings Per Share (EPS)
- 1.43
Cash Flow
In the last 12 months, operating cash flow was 1.99B and capital expenditures 34.00M, giving a free cash flow of 2.03B billion.
- Operating Cash Flow
- 1.99B
- Free Cash Flow
- 2.03B
- Free Cash Flow per Share
- 1.80
Dividends & Yields
Medline pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.70%
- Earnings Yield
- 1.29%
Stock Price Statistics
- Beta
- 0.98
- 52-Week Price Change
- -1.59%
- 50-Day Moving Average
- 34.53
- 200-Day Moving Average
- 39.56
- Relative Strength Index (RSI)
- 73.18
- Average Volume (3m)
- 8.73M
Important Dates
Medline upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Medline as a current ratio of 4.29, with Debt / Equity ratio of 116.99%
- Current Ratio
- 4.29
- Quick Ratio
- 2.37
- Debt to Market Cap
- 0.37
- Net Debt to EBITDA
- 4.70
- Interest Coverage Ratio
- 2.72
Taxes
In the past 12 months, Medline has paid 91.00M in taxes.
- Income Tax
- 91.00M
- Effective Tax Rate
- 0.07
Enterprise Valuation
Medline EV to EBITDA ratio is 18.39, with an EV/FCF ratio of 16.40.
- EV to Sales
- 1.46
- EV to EBITDA
- 18.39
- EV to Free Cash Flow
- 16.40
- EV to Operating Cash Flow
- 16.68
Balance Sheet
Medline has $2.68B in cash and marketable securities with $12.64B in debt, giving a net cash position of -$9.96B billion.
- Cash & Marketable Securities
- $2.68B
- Total Debt
- $12.64B
- Net Cash
- -$9.96B
- Net Cash Per Share
- -$11.36
- Tangible Book Value Per Share
- -$2.96
Margins
Gross margin is 25.16%, with operating margin of 5.68%, and net profit margin of 2.24%.
- Gross Margin
- 25.16%
- Operating Margin
- 5.68%
- Pretax Margin
- 3.64%
- Net Profit Margin
- 2.24%
- EBITDA Margin
- 5.89%
- EBIT Margin
- 3.38%
Analyst Forecast
The average price target for Medline is $44.94, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $44.94
- Price Target Upside
- 11.38% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 20
- Revenue Growth Forecast
- 12.12%
- EPS Growth Forecast
- -46.11%
Scores
- Smart Score
- 7
- AI Score
- 60
